Bladex to Host Virtual Investor Day on March 24, 2026

Bladex (NYSE: BLX, or “the Bank”), a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced that it will host a virtual investor day on Tuesday, March 24, 2026, from 10:00 a.m. to 12:30 p.m. ET. At this […]

HPQ Silicon and Novacium Achieve IEC 62133 Certification – Major Step Toward Global Commercialization of High-Performance Li-Ion Cells

— IEC 62133 certification confirms that HPQ Endura+ and Novacium lithium-ion cells meet the world’s leading international safety standard for portable rechargeable batteries — Combined with existing UN 38.3 (transport) and UL 1642 (U.S.) certifications, this completes the core set of globally recognized safety approvals — Removes major regulatory barriers and accelerates commercial discussions, customer

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its fourth quarter earnings conference call will be webcast on Tuesday, February 10, 2026, at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET. A live audio webcast can

ValueLabs to Continue Growth Journey as an Independent, Founder-Led Company

ValueLabs, a global digital engineering and enterprise AI company, today announced that it will continue its growth journey as an independent, founder-led organization following the completion of a strategic review that included discussions with global investors and strategic partners. https://mma.prnewswire.com/media/1343811/ValueLabs_Logo.jpg Over the past several months, ValueLabs evaluated whether an external partnership would meaningfully support its

PK CONSUMER HEALTH ANNOUNCES THE ACQUISITION OF PUHDISTAMO, A LEADING NORDIC CONSUMER HEALTHCARE PLAYER

PK Consumer Health (“PK”), a portfolio company of Avista Healthcare Partners and Damier Group, is pleased to announce that it has signed an agreement to acquire Puhdistamo – Real Foods Oy (“Puhdistamo”), a fast-growing Nordic player in the vitamins, minerals and supplements (“VMS”), sports nutrition and functional drinks markets. This acquisition marks an important milestone

North American Niobium and Critical Minerals Corp. Confirms Magnet REE and Niobium Mineralization at Blanchette, Bardy and Sabot Properties, Including 1.82% TREO and 0.14% Nb₂Oâ‚

North American Niobium and Critical Minerals Corp. Confirms Magnet REE and Niobium Mineralization at Blanchette, Bardy and Sabot Properties, Including 1.82% TREO and 0.14% Nbâ‚‚Oâ‚… GlobeNewswire January 15, 2026 Vancouver, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) — North American Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: KS82.F) (OTCQB: NIOMF) (“North American Niobium” or

Rio Silver Provides Shareholders With a Five-Step Plan to Access High-Grade Surface Silver and Advance Toward Near-Term Production at Maria Norte

Rio Silver Provides Shareholders With a Five-Step Plan to Access High-Grade Surface Silver and Advance Toward Near-Term Production at Maria Norte Surface-accessible high-grade silver, rapid development, and nearby operating mills position the Company for a capital-efficient path toward potential cash flow GlobeNewswire January 15, 2026 VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) — Rio

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO(R)

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO(R) GlobeNewswire January 15, 2026 Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked No. 6 nationally for Urology by US News & World Report(R) for 2025-26 TORONTO,

Titanium Enters into Arrangement Agreement for Going-Private Transaction at $2.22 Per Share

Titanium Enters into Arrangement Agreement for Going-Private Transaction at $2.22 Per Share GlobeNewswire January 15, 2026 Key highlights: Titanium shareholders (other than the Rolling Shareholders) will receive all-cash consideration of $2.22 per Common Share, representing a 41% premium to the last closing price of the Common Shares traded on the TSX on January 14, 2026

Scroll to Top